The Uromigos Episode 31: A Phase 2 Study of Nivolumab With the Addition of Ipilimumab Upon Progression in Renal Cancer

Mike Atkins describes the results of this phase 2 study, which helps shed light on the role of ipilimumab and nivolumab in renal cancer.